HADEEL ALI HAMDAN: Open Payments
NPI 1407501752 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 30 payments from 11 companies in 2025. Trend: 2023 $464 · 2024 $692 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $289 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Exact Sciences Corporation | 3 | $58 |
| PFIZER INC. | 3 | $54 |
| GlaxoSmithKline, LLC. | 2 | $53 |
| Amgen Inc. | 3 | $50 |
| Boston Scientific Corporation | 2 | $45 |
| Lilly USA, LLC | 2 | $44 |
| Noven Therapeutics, LLC | 1 | $25 |
| Neuronetics, Inc. | 1 | $18 |
Products named: Ozempic, Wegovy, Cologuard Collection Kit, TRELEGY ELLIPTA, AIRSUPRA, ZEPBOUND, Rybelsus, OTEZLA.
Industry payments across FL — which companies pay providers there.
